CD200 Expression
antitumor immunity, cd200 expression, macrophage, XVIVO
“I reviewed the video this morning and think it looks truly exceptional—I had high expectations to begin with and you have actually exceeded them.” CEO, Threshold Pharmaceuticals
Biotechnology company Dendreon Corporation, has developed what is believed to be a method for getting around prostate ... Read More
Harvard University selected XVIVO to develop an animation that would take their cellular biology students on a journe ... Read More
Dengue was created for Irene Bosch, Ph.D. at University of Massachusetts and Yorgo Modis, Ph.D. from Yale University. ... Read More
Scientists at Zirus are working on a new technology platform to cure and manage viral infection through the developme ... Read More
... Read More